+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment failures in onychomycosis Fungal and drug factors



Treatment failures in onychomycosis Fungal and drug factors



Mycoses 45(Supplement 2): 22




(PDF emailed within 0-6 h: $19.90)

Accession: 035980162

Download citation: RISBibTeXText

DOI: 10.1111/j.1439-0507.2002.tb04611.x


Related references

Treatment failures and relapses in onychomycosis: a stubborn clinical problem. Dermatology 207(3): 255-260, 2003

Onychomycosis from Aspergillus melleus, a Novel Pathogen for Humans. Fungal Identification and in vitro Drug Susceptibility. Experimental Dermatology 24(12): 966-968, 2016

An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates. European Journal of Pharmaceutics and Biopharmaceutics 102: 178-184, 2016

Study of antiretroviral mutants in HIV patients with treatment failures and the effect of risk factors in the virological failures. Revista do Instituto de Medicina Tropical de Sao Paulo 47(6): 327-331, 2006

Antibiofilm Treatment for Onychomycosis and Chronic Fungal Infections. Skin Appendage Disorders 4(3): 136-140, 2018

A rationale for systemic treatment in onychomycosis with negative results on fungal examination. Clinical and Experimental Dermatology 36(7): 724-727, 2011

Prevalence, Risk Factors, and Type of Organism in Fungal Foot Infection and Toenail Onychomycosis in Thai Diabetic Patients. Journal of the Medical Association of Thailand 99(6): 659-664, 2018

Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis. Journal of the American Osteopathic Association 97(6): 339-346, 1997

Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. Drugs 49(1): 103-120, 1995

Voriconazole and fungal keratitis: a report of two treatment failures. Journal of Ocular Pharmacology and Therapeutics 22(6): 437-439, 2007

Therapeutic surgery in failures of medical treatment for fungal keratitis. British Journal of Ophthalmology 59(7): 366-371, 1975

Analysis of amphotericin treatment failures in systemic fungal disease. Annals of the New York Academy of Sciences 89: 277-282, 1960

A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. Journal of the American Academy of Dermatology 43(4): 641-648, 2000

Recent progress in the study of fungal virulence factors and identification of new targets of anti-fungal drug using proteomic and transcriptomic analysis. Nihon Rinsho. Japanese Journal of Clinical Medicine 66(12): 2255-2260, 2009

Fungal colonization in the neonatal intensive care unit: risk factors, drug susceptibility, and association with invasive fungal infections. American Journal of Perinatology 24(2): 127-135, 2007